Cerulean Pharma – Focused on novel, nanotechnology-based therapeutics

Cerulean Pharma is a private biopharmaceutical company focused on the development of novel, nanotechnology-based therapeutics in the areas of oncology, cardiovascular, autoimmune and inflammatory diseases.

Cerulean is pursuing three key strategies to achieve leadership in Nanopharmaceuticals:

  • Cerulean is focused on achieving rapid and clinically significant human proof of concept with its technology.
  • Cerulean is building a deep and diversified product pipeline, leveraging its proprietary nanotechnology platform.
  • Cerulean is using a multi-faceted business model, with plans to retain certain key products for development and commercialization to achieve full company value creation, while at the same time collaborating on other products to leverage the resources and capabilities of partners.

Cerulean has assembled a world-class management team, board of directors and scientific advisory board that collectively have a significant track record of business building, product development and scientific breakthroughs. Cerulean was founded in 2006 and is located in Cambridge, Massachusetts.